Rachel is a Commercial Director with over 15 years’ experience in pharmaceutical market research consulting, recognized for bringing a commercial lens to innovation. She combines strategic client leadership with a focus on embedding new AI solutions into research approaches that deliver stronger commercial impact.
With a strong record of championing new ways of working that keep organizations ahead of change, Rachel partners with clients to identify where AI-enabled methods can accelerate evidence generation, improve decision-making, and uncover new opportunities.
Rachel also plays an active role in shaping the industry conversation on how AI can transform pharmaceutical market research. Within Inizio, she contributes to initiatives that explore and implement cutting-edge approaches, ensuring that commercial priorities and technological advancements are aligned.